biotech
Bio-AnalystSupplement research
person

Glycine

Selected research topic

Immune and respiratory health

Some publications still need interpretation checks and are kept separate from the findings below.

Publications for this topic
2
Human comparison publications
0
Publications needing review
2

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (1)
  • development of chronic inflammation · Distinct papers needing additional review: 1Direction unclear: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Representative outcome and study details

Some findings are held for review

Some papers have not cleared source or result review, so their findings are not summarized yet.

No confirmed result is available to summarize with study conditions.

1 publications linked to this result (1 awaiting review included)

  • Those papers are not summarized until review is complete.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: C

The 32.2 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 93

Papers linked to this topic 2 · distinct papers 2 · comparison findings need further review · papers needing additional review 2

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • development of chronic inflammation: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

What the research found

development of chronic inflammation

The study needs further checking before its result can be interpreted.

Review · Unknown intervention · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

No combination cautions are available to show in the current data. This does not guarantee safety.

Review 1 combination findings and 0 findings that outperformed an ingredient alone.

Reported improvements with combinations

Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.

Combinations with reported improvement

The combination showed improvement, but each ingredient's contribution is unclear.

NACIn a randomized clinical trial of older adults, GlyNAC (a combination of glycine and NAC) supplementation for 16 weeks improved glutathione deficiency, oxidative stress, and mitochondrial dysfunction compared to placebo.